ethylene oxide has been researched along with warfarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, H; Guo, L; Jiang, X; Mei, H; Pang, Z; Qian, Y; Ren, J; Shen, S; Zhang, B | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L | 1 |
2 other study(ies) available for ethylene oxide and warfarin
| Article | Year |
|---|---|
Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes.
Topics: Animals; Blood-Brain Barrier; Cattle; Cell Line, Transformed; Coumarins; Drug Carriers; Ethylene Oxide; Kinetics; Lactones; Mice; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Surface Properties; Thermodynamics; Transcytosis | 2012 |
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coumarins; Diagnostic Imaging; Drug Delivery Systems; Endocytosis; Ethylene Oxide; Glioblastoma; Kaplan-Meier Estimate; Lactones; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; Paclitaxel; Protamines; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Tissue Distribution | 2013 |